NeuroSense Therapeutics Ownership | Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics Ownership Summary

NeuroSense Therapeutics is owned by 3.58% institutional investors, 31.23% insiders, and 65.19% retail investors. Jane street group is the largest institutional shareholder, holding 0.36% of NRSN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.07% of its assets in NeuroSense Therapeutics shares.

NRSN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	NeuroSense Therapeutics	3.58%	31.23%	65.19%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Jane street group	64.64K	0.36%	$77.56K
Hrt financial lp	64.39K	0.36%	$77.00K
Xtx topco	41.90K	0.23%	$50.28K
Meitav investment house	40.00K	0.22%	$48.00K
Stratos wealth partners	20.00K	0.11%	$24.00K
Commonwealth equity services	16.25K	0.09%	$20.00K
Geode capital management	15.87K	0.09%	$19.04K
Two sigma securities	15.02K	0.08%	$18.02K
Warberg asset management	10.70K	0.06%	$12.84K
Morgan stanley	1.50K	0.01%	$1.68K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Xtx topco	41.90K	0.00%	$50.28K
Two sigma securities	15.02K	0.00%	$18.02K
Warberg asset management	10.70K	0.00%	$12.84K
Meitav investment house	40.00K	0.00%	$48.00K
Hrt financial lp	64.39K	0.00%	$77.00K
Stratos wealth partners	20.00K	0.00%	$24.00K
Cantor fitzgerald, l. p.	-	-	-
Ubs group	-	-	-
Armistice capital	-	-	-
Qube research	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Jane street group	64.64K	-	64.64K
Hrt financial lp	64.39K	0.00%	64.39K
Stratos wealth partners	20.00K	0.00%	20.00K
Two sigma securities	15.02K	0.00%	15.02K
Warberg asset management	10.70K	0.00%	10.70K

Top Sellers

Holder	Shares	% Assets	Change
Armistice capital	-	-	-1.58M
Cantor fitzgerald, l. p.	-	-	-79.49K
Renaissance	-	-	-71.10K
Woodline partners lp	-	-	-19.58K
Ubs group	-	-	-11.93K

New Positions

Holder	Shares	% Assets	Change	Value
Jane street group	64.64K	-	64.64K	$77.56K
Hrt financial lp	64.39K	0.00%	64.39K	$77.00K
Stratos wealth partners	20.00K	0.00%	20.00K	$24.00K
Two sigma securities	15.02K	0.00%	15.02K	$18.02K
Warberg asset management	10.70K	0.00%	10.70K	$12.84K

Sold Out

Holder	Change
Qube research	-54.00
Ubs group	-11.93K
Woodline partners lp	-19.58K
Renaissance	-71.10K
Cantor fitzgerald, l. p.	-79.49K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	13	85.71%	646,513	186.89%	3	229.84%	10	150.00%	1	-
Sep 30, 2024	7	-	225,356	-86.52%	1	1.06%	4	100.00%	-	-100.00%
Jun 30, 2024	7	-12.50%	1,671,167	899.94%	10	918.60%	2	-33.33%	1	-
Mar 31, 2024	8	-	167,126	18.03%	1	84.21%	3	-40.00%	1	-
Dec 31, 2023	8	60.00%	141,595	-81.83%	1	4.47%	5	150.00%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Nasdaq Composite Index	15.87K	0.07%	-

NRSN Ownership FAQ

Who Owns NeuroSense Therapeutics?

NeuroSense Therapeutics shareholders are primarily institutional investors at 3.58%, followed by 31.23% insiders and 65.19% retail investors. The average institutional ownership in NeuroSense Therapeutics's industry, Biotech Stocks , is 68.48%, which NeuroSense Therapeutics falls below.

Who owns the most shares of NeuroSense Therapeutics?

NeuroSense Therapeutics’s largest shareholders are Jane street group (64.64K shares, 0.36%), Hrt financial lp (64.39K shares, 0.36%), and Xtx topco (41.9K shares, 0.23%). Together, they hold 0.95% of NeuroSense Therapeutics’s total shares outstanding.

Does Blackrock own NeuroSense Therapeutics?

BlackRock is not among the top 10 institutional shareholders of NeuroSense Therapeutics.

Who is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested?

Xtx topco is NeuroSense Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 41.9K NeuroSense Therapeutics shares, valued at 50.28K$.

Who is the top mutual fund holder of NeuroSense Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NeuroSense Therapeutics shares, with 0.07% of its total shares outstanding invested in 15.87K NeuroSense Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools